FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311542494> ?p ?o ?g. }

• W4311542494 endingPage "492" @default.
• W4311542494 startingPage "492" @default.
• W4311542494 abstract "Introduction: Glycemic control is an important component of quality improvement bundles within the ICU. Dysglycemia among intensive care unit (ICU) patients has been associated with greater morbidity and mortality. The COVID-19 pandemic has been shown to influence hypoglycemia in patients presenting to the emergency department. The purpose of this study is to evaluate risk factors for dysglycemia during the COVID-19 pandemic in critically ill ICU patients on subcutaneous insulin. Methods: Single-center, retrospective quality improvement study of adult critically ill patients admitted to the ICU in 2020. Patients were included if they were on subcutaneous insulin and primarily managed by an intensive care unit multidisciplinary team. Patients were excluded with active endocrinology consultation or receiving intravenous insulin infusion. Rates of hyperglycemia (blood glucose (BG) greater than or equal to 180 mg/dL), severe hyperglycemia (BG > 300 mg/dL), hypoglycemia (less than or equal to 70 mg/dL), or severe hypoglycemia (BG < 54 mg/dL) were evaluated. Basic patient demographics, including history of diabetes, steroid use, COVID-19 diagnosis were obtained. Regression analysis was performed adjusting for age, past medical history of diabetes, use of corticosteroid medications, COVID-19 diagnosis and use of a self-adjusting insulin calculator. Results: There were 244 adult ICU patients and 2,198 patient days evaluated in this study. History of diabetes was associated with greater odds of hyperglycemia (odds ratio (OR) 2.09 (1.57-2.78), p< 0.01), severe hyperglycemia (OR 1.82 (1.02-3.24), p=0.04), and lower risk for severe hypoglycemia (OR 0.24 (0.07-0.81), p=0.02). Corticosteroid use was associated with greater risk of hyperglycemia (OR 3.04 (2.31-3.99), p< 0.01) and severe hyperglycemia (OR 4.54 (2.59-7.95), p< 0.01), with no significant difference in hypoglycemia. COVID-19 diagnosis was associated with greater hyperglycemia (OR 1.49 (1.11-2), p=0.007) and hypoglycemia (OR 3.93 (1.32-11.73), p=0.01). Conclusions: In our quality improvement analysis, dysglycemia was found to be more prevalent in patients with corticosteroid use, history of diabetes and patients with a COVID-19 diagnosis. Larger studies would be beneficial to confirm these results." @default.
• W4311542494 created "2022-12-27" @default.
• W4311542494 creator A5042837290 @default.
• W4311542494 creator A5047461763 @default.
• W4311542494 creator A5062296498 @default.
• W4311542494 creator A5064958981 @default.
• W4311542494 creator A5084285178 @default.
• W4311542494 date "2022-12-15" @default.
• W4311542494 modified "2023-09-26" @default.
• W4311542494 title "998: RISK FACTORS FOR DYSGLYCEMIA IN THE ICU DURING THE COVID-19 PANDEMIC" @default.
• W4311542494 doi "https://doi.org/10.1097/01.ccm.0000909720.38326.0e" @default.
• W4311542494 hasPublicationYear "2022" @default.
• W4311542494 type Work @default.
• W4311542494 citedByCount "0" @default.
• W4311542494 crossrefType "journal-article" @default.
• W4311542494 hasAuthorship W4311542494A5042837290 @default.
• W4311542494 hasAuthorship W4311542494A5047461763 @default.
• W4311542494 hasAuthorship W4311542494A5062296498 @default.
• W4311542494 hasAuthorship W4311542494A5064958981 @default.
• W4311542494 hasAuthorship W4311542494A5084285178 @default.
• W4311542494 hasBestOaLocation W43115424941 @default.
• W4311542494 hasConcept C126322002 @default.
• W4311542494 hasConcept C134018914 @default.
• W4311542494 hasConcept C156957248 @default.
• W4311542494 hasConcept C177713679 @default.
• W4311542494 hasConcept C194828623 @default.
• W4311542494 hasConcept C2776376669 @default.
• W4311542494 hasConcept C2779306644 @default.
• W4311542494 hasConcept C2780473172 @default.
• W4311542494 hasConcept C2780668416 @default.
• W4311542494 hasConcept C555293320 @default.
• W4311542494 hasConcept C71924100 @default.
• W4311542494 hasConceptScore W4311542494C126322002 @default.
• W4311542494 hasConceptScore W4311542494C134018914 @default.
• W4311542494 hasConceptScore W4311542494C156957248 @default.
• W4311542494 hasConceptScore W4311542494C177713679 @default.
• W4311542494 hasConceptScore W4311542494C194828623 @default.
• W4311542494 hasConceptScore W4311542494C2776376669 @default.
• W4311542494 hasConceptScore W4311542494C2779306644 @default.
• W4311542494 hasConceptScore W4311542494C2780473172 @default.
• W4311542494 hasConceptScore W4311542494C2780668416 @default.
• W4311542494 hasConceptScore W4311542494C555293320 @default.
• W4311542494 hasConceptScore W4311542494C71924100 @default.
• W4311542494 hasIssue "1" @default.
• W4311542494 hasLocation W43115424941 @default.
• W4311542494 hasLocation W43115424942 @default.
• W4311542494 hasOpenAccess W4311542494 @default.
• W4311542494 hasPrimaryLocation W43115424941 @default.
• W4311542494 hasRelatedWork W1969810409 @default.
• W4311542494 hasRelatedWork W1975738245 @default.
• W4311542494 hasRelatedWork W2013297285 @default.
• W4311542494 hasRelatedWork W2017030704 @default.
• W4311542494 hasRelatedWork W2083314455 @default.
• W4311542494 hasRelatedWork W2157574216 @default.
• W4311542494 hasRelatedWork W2159992225 @default.
• W4311542494 hasRelatedWork W2160583507 @default.
• W4311542494 hasRelatedWork W2585474738 @default.
• W4311542494 hasRelatedWork W4307560231 @default.
• W4311542494 hasVolume "51" @default.
• W4311542494 isParatext "false" @default.
• W4311542494 isRetracted "false" @default.
• W4311542494 workType "article" @default.